ADILNasdaqPharmaceutical PreparationsFiscal year ends December 31
ADIAL PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.62+0.13 (+3.72%)
Close on Oct 19, 2026
- Market cap
- $16.73M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Adial Pharmaceuticals has not reported a dividend
No dividend per share appears in Adial Pharmaceuticals's annual filings since fiscal 2016.